左侧乳腺癌切线调强放疗与切线容积旋转调强的比较:第二癌症诱发风险与靶区覆盖的权衡
本研究为计划学研究,纳入20例左侧乳腺癌保乳术后患者,在深吸气屏气(DIBH)体位下比较切线调强放疗(t-IMRT)与切线容积旋转调强放疗(t-VMAT)的剂量学差异。结果显示t-IMRT显著降低心脏平均剂量26%、左前降支平均剂量20%、机器跳数31%、正常组织积分剂量19%及全身V5% 24%,且对侧肺与对侧乳腺的第二癌症超额绝对风险(EAR)更低;t-VMAT则均匀性指数与适形性指数略优。
要点
- t-IMRT较t-VMAT显著降低心脏平均剂量26%(p=0.002)和左前降支平均剂量20%(p=0.03)。
- t-IMRT使机器跳数降低31%、正常组织积分剂量降低19%、全身V5%降低24%。
- t-VMAT的适形性指数与均匀性指数分别优于t-IMRT 2%和0.4%,可用于需充分覆盖内侧淋巴靶区者。
核心结论
- 在左侧乳腺癌DIBH放疗中,t-IMRT较t-VMAT显著降低心脏、左前降支剂量及正常组织积分剂量和全身V5%,对侧肺与对侧乳腺的EAR更低。
- t-VMAT的均匀性和适形性更优,可能在需要充分覆盖内侧淋巴靶区的个体病例中有价值。
研究设计与样本
- 计划学研究,纳入20例左侧乳腺癌保乳术后患者。
- 每例患者分别生成DIBH下t-IMRT计划(5–7个射束)和t-VMAT计划(四个旋转),均实现95%体积接受95%剂量覆盖。
- 基于剂量体积直方图评估心脏、左前降支、双肺、对侧乳腺剂量、机器跳数、全身V5%、正常组织积分剂量、均匀性指数、适形性指数及第二癌症EAR。
主要发现
- t-IMRT较t-VMAT显著降低心脏平均剂量26%(p=0.002)和左前降支平均剂量20%(p=0.03)。
- t-IMRT较t-VMAT显著降低机器跳数31%(p=0.000004)、正常组织积分剂量19%(p=0.000005)和全身V5% 24%(p=0.0007)。
- t-IMRT较t-VMAT使左肺平均剂量增加5%(p=0.006),右肺及对侧乳腺平均剂量无显著差异。
- t-VMAT较t-IMRT显著改善适形性指数2%(p=0.001)和均匀性指数0.4%(p=0.00001)。
- t-IMRT的对侧肺和对侧乳腺EAR显著更低(2–5/10,000人年),但同侧肺无显著差异。
关键数值与推荐
- t-IMRT心脏平均剂量较t-VMAT降低26%(p=0.002),左前降支平均剂量降低20%(p=0.03)。
- t-IMRT机器跳数降低31%(p=0.000004),正常组织积分剂量降低19%(p=0.000005),全身V5%降低24%(p=0.0007)。
- t-IMRT左肺平均剂量增加5%(p=0.006)。
- t-VMAT适形性指数改善2%(p=0.001),均匀性指数改善0.4%(p=0.00001)。
- t-IMRT对侧肺和对侧乳腺EAR降低2–5/10,000人年。
临床怎么用
- 对于左侧乳腺癌保乳术后DIBH放疗,优先考虑t-IMRT以降低心脏、左前降支剂量及正常组织低剂量照射。
- 当内侧淋巴靶区覆盖不足或需更好适形性时,可个体化选用t-VMAT。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adjuvant radiotherapy is the standard treatment after breast-conserving surgery. According to meta-analyses, adjuvant 3d-conventional irradiation reduces the risk of local recurrence and thereby improves long-term survival by 5-10%. However, there is an unintended exposure of organs such as the heart, lungs and contralateral breast. Irradiation of the left breast has been related to long-term effects like increased rates of coronary events as well as second cancer induction. Modern radiotherapy techniques such as tangential intensity modulated radiotherapy (t-IMRT) and tangential volumetric modulated arc therapy (t-VMAT) and particularly deep inspiration breath hold (DIBH) technique have been developed in order to improve coverage of target volume and to reduce dose to normal tissue. The aim of this study was to compare t-IMRT-plans with t-VMAT-plans in DIBH position for left-sided breast irradiation in terms of normal tissue exposure, i.e. of lungs, heart, left anterior descending coronary artery (LADCA), as well as homogeneity (HI) and conformity index (CI) and excess absolute risk (EAR) for second cancer induction for organs at risk (OAR) after irradiation. METHODS: Twenty patients, diagnosed with left-sided breast cancer and treated with breast-preserving surgery, were included in this planning study. For each patient DIBH-t-IMRT plan using 5 to 7 beams and t-VMAT plan using four rotations were generated to achieve 95% dose coverage to 95% of the volume. Data were evaluated on the basis of dose-volume histograms: Cardiac dose and LADCA (mean and maximum dose, D25% and D45%), dose to ipsilateral and contralateral lung (mean, D20%, D30%), dose to contralateral breast (mean dose), total monitor units, V5% of total body and normal tissue integral dose (NTID). In addition, homogeneity index and conformity index, as well as the excess absolute risk (EAR) to estimate the risk of second malignancy were calculated. RESULTS: T-IMRT showed a significant reduction in mean cardiac dose of 26% (p = 0.002) compared to t-VMAT, as well as a significant reduction in the mean dose to LADCA of 20% (p = 0.03). Following t-IMRT, mean dose to the left lung was increased by 5% (p = 0.006), whereas no significant difference was found in the mean dose to the right lung and contralateral breast between the two procedures. Monitor units were 31% (p = 0.000004) lower for t-IMRT than for t-VMAT. T-IMRT technique significantly reduced normal tissue integral dose (NTID) by 19% (p = 0.000005) and the V5% of total body by 24% (p = 0.0007). In contrast, t-VMAT improved CI and HI by 2% (p = 0.001) and 0.4% (p = 0.00001), respectively. EAR with t-IMRT was significantly lower, especially for contralateral lung and contralateral breast (2-5/10,000 person years) but not for ipsilateral lung. CONCLUSION: Compared to t-VMAT, t-IMRT in left-sided breast irradiation significantly reduced dose to organs at risk as well as normal tissue integral dose, and V5% total body. EAR with t-IMRT was significantly lower for contralateral lung and contralateral breast. T-VMAT, however, achieved better homogeneity and conformity. This may be relevant in individual cases where sufficient coverage of medial lymphatic target volumes is warranted.
引用
- Karpf D, Sakka M, Metzger M, et al. Left breast irradiation with tangential intensity modulated radiotherapy (t-IMRT) versus tangential volumetric modulated arc therapy (t-VMAT): trade-offs between secondary cancer induction risk and optimal target coverage. Radiat Oncol. 2019. PMID: 31477165. doi:10.1186/s13014-019-1363-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。